Haig Aghajanian

Haig Aghajanian

Company: Capstan Therapeutics

Job title: Co-Founder & Vice President of Research

Seminars:

Panel Discussion: Applying In Vivo CAR-T Cell Therapy For Oncology & Beyond 12:30 pm

• Addressing the question: how in vivo CAR T cell therapy obviates current ex vivo bottlenecks including access, efficacy and toxicity • Achieving a transient vs longer term effect for different indicationsRead more

day: Day One

In Vivo Generated CAR T Cells to Reverse Fibrosis & Restore Cardiac Function 12:00 pm

• Generating transient, functional antifibrotic CAR T cells in vivo by delivering modified mRNA in T cell-targeted LNPs • Observing efficient delivery and translation of modified mRNA encoding a CAR to T lymphocytes and a reduction in fibrosis • Leveraging this technology as a therapeutic platform to treat various pathologies beyond cardiac diseaseRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.